HomeAVBP • NASDAQ
add
Arrivent Biopharma Inc
Previous close
$19.02
Day range
$18.93 - $19.78
Year range
$15.47 - $36.20
Market cap
799.61M USD
Avg Volume
299.42K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
In the news
Financials
Income Statement
Revenue
Net income
| (USD) | Jun 2025info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 33.62M | 30.84% |
Net income | -31.40M | -43.55% |
Net profit margin | — | — |
Earnings per share | -0.90 | -38.46% |
EBITDA | — | — |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Jun 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 235.69M | -21.09% |
Total assets | 269.51M | -12.74% |
Total liabilities | 19.64M | 61.00% |
Total equity | 249.87M | — |
Shares outstanding | 40.57M | — |
Price to book | 2.86 | — |
Return on assets | -34.66% | — |
Return on capital | -37.14% | — |
Cash Flow
Net change in cash
| (USD) | Jun 2025info | Y/Y change |
|---|---|---|
Net income | -31.40M | -43.55% |
Cash from operations | -26.12M | -36.87% |
Cash from investing | 13.91M | — |
Cash from financing | 75.11M | 20,592.56% |
Net change in cash | 62.90M | 435.93% |
Free cash flow | -15.73M | -21.65% |
About
Founded
2021
Headquarters
Website
Employees
52
